GRAL
GRAIL, LLC
NASDAQ: GRAL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$54.48
+9.64% today
Updated 2026-04-30
Market cap
$2.14B
P/E ratio
—
P/S ratio
14.55x
EPS (TTM)
$-11.11
Dividend yield
—
52W range
$30 – $119
Volume
1.4M
GRAIL, LLC (GRAL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $686.85M | $635.52M | $706.30M | $9.74B | $5.60B | $4.56B | $2.98B | — |
| Cash & equivalents | $95.09M | $143.19M | $170.19M | $221.16M | $241.60M | $97.29M | $214.23M | — |
| Current assets | $649.23M | $557.51M | $595.92M | $242.73M | $295.63M | $156.06M | $819.86M | — |
| Total liabilities | $86.47M | $84.99M | $144.46M | $307.40M | $955.94M | $910.74M | $479.90M | — |
| Current liabilities | $74.16M | $44.93M | $83.97M | $97.89M | $134.94M | $163.61M | $76.92M | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | $600.37M | $550.53M | $561.84M | $9.43B | $4.65B | $3.65B | $2.50B | — |
| Retained earnings | $-1.06B | $-1.31B | $-1.62B | $-911.54M | $-6.31B | $-7.78B | $-9.80B | — |
| Accounts receivable | — | — | — | $6.88M | $18.61M | $22.35M | $24.64M | — |
| Inventory | — | $-584000.00 | — | — | $19.75M | $21.70M | $18.63M | — |
| Goodwill | — | — | — | $6.20B | $1.50B | $888.94M | $0.00 | — |